-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma Reports NVG-291 Achieves Durable Functional Gains in Chronic Spinal Cord Injury Trial

Reuters·11/24/2025 12:02:11

Please log in to view news